ID   C5B7
AC   CVCL_6316
DR   CLO; CLO_0002137
DR   ATCC; CRL-8753
DR   BioSample; SAMN03471207
DR   Wikidata; Q54808209
RX   Patent=US5662905;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8753.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8753
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 12
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB43 ! C5D5
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   Patent=US5662905;
RA   Siadak A.W., Rosok M.J.;
RT   "Monoclonal antibody compositions cross-reactive and cross-protective
RT   against P. aeruginosa serotypes.";
RL   Patent number US5662905, 02-Sep-1997.
//